Riverside Capital Investments

The Riverside Company is a global private equity firm that specializes in investing in growing enterprises valued at up to $400 million. Within the life sciences and healthcare sectors, the firm maintains a dedicated specialization, having completed over 170 investments in healthcare providers, medical device manufacturers, and pharmaceutical services. Riverside's healthcare portfolio includes a diverse range of companies such as BioAgilytix, a leading bioanalytical testing laboratory, and various specialized clinical research organizations (CROs). The firm provides strategic capital and operational support to help healthcare companies scale their operations, expand geographically, and enhance their service offerings. With a global presence across North America, Europe, and the Asia-Pacific region, Riverside is a prominent financial partner for middle-market healthcare and biotech-related businesses.